These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10477587)

  • 1. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
    Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
    J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
    J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
    J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
    Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.
    Wu ZQ; Vos Q; Shen Y; Lees A; Wilson SR; Briles DE; Gause WC; Mond JJ; Snapper CM
    J Immunol; 1999 Jul; 163(2):659-67. PubMed ID: 10395655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
    Andreasen SO; Christensen JE; Marker O; Thomsen AR
    J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
    Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
    Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus.
    Varga SM; Welsh RM
    J Immunol; 1998 Oct; 161(7):3215-8. PubMed ID: 9759834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
    Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
    J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza-induced, helper-independent CD8+ T cell responses use CD40 costimulation at the late phase of the primary response.
    Seah SG; Brady JL; Carrington EM; Ng WC; Sutherland RM; Hancock MS; La Gruta NL; Brown LE; Turner SJ; Lew AM; Zhan Y
    J Leukoc Biol; 2013 Jan; 93(1):145-54. PubMed ID: 23108101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
    Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
    Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships.
    Sharma MD; Leite de Moraes M; Zavala F; Pontoux C; Papiernik M
    J Immunol; 1998 Nov; 161(10):5357-65. PubMed ID: 9820509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.